able in low-flow systems, while the maintenance of sufficient humidification and heat can be challenging in highflow systems. Due to these shortcomings, improved oxygen delivery methods are needed for the safe and effective treatment of patients with hypoxia.
As an alternative to existing methods, high flow nasal cannula (HFNC) using heated and humidified gas has emerged as a novel oxygen delivery method. HFNC has been historically used for the treatment of hypoxic neonatal and pediatric patients [2] . Recently, experiences have produced some positive results with a reduced risk of tracheal intubation rates and mortality shown in adult patients with hypoxia [3] .
The benefits of HFNC are thought to arise from the effects of the heated and humidified gas, the high flow rate (which minimizes entrainment of room air), increased ventilation efficiency via the elimination of nasopharyngeal dead space, the positive end-expiratory pressure (PEEP) effect and reductions in paradoxical abdominal movement [4] . In terms of the effect on lung volume, the global and regional ventilation of the lung is known to increase during HFNC use in postoperative and healthy subjects, which is thought to be a result of the PEEP effect [5, 6] . However, it remains to be determined how regional ventilation in patients with hypoxia during HFNC compares with conventional nasal cannula (NC).
MaterIals and Methods

Participants
Eligible patients were receiving oxygen via NC at 6 L/min or less due to hypoxia, which was defined as an oxygen saturation (SaO 2 ) of less than 90% in room air.
Patients with unstable vital signs, severe hypoxia, impending respiratory failure, symptomatic ischemic heart disease, and those who were unable to use HFNC for reasons such as nasopharyngeal deformities were excluded.
The eligibility and exclusion criteria are shown in Table 1 .
Study Design
This was a randomized, controlled, cross-over, within- Patients received both of the two types of oxygen therapy in turn: NC followed by HFNC or HFNC followed by NC.
Assignment to one of these sequences occurred using a predefined randomization table generated by Microsoft Excel (Microsoft Redmond, WA, USA). Patients received each type of oxygen therapy for 20 minutes. One of the authors (DHL) and a respiratory therapist attended at the bedside executing the study and monitoring the subjects. Changeover from one oxygen therapy to the other oxygen therapy was done in less than 2 minutes.
During the study, vital signs including oxygen saturation were monitored. Electric impedance tomography (EIT) data were recorded at the end of the 20 minutes session of both oxygen therapies using a separate regional ventilation monitor (PulmoVista 500; Dräger Medical, Lübeck, Germany). The data samples for analysis were collected at the end of each type of oxygen therapy, with patients also answering a questionnaire on perceived discomfort.
The overall study design is shown in Figure 1 .
Oxygen Therapy
An OmniOx System (MEK-ICS, Paju, Korea) was used to administer HFNC. Initially, the gas flow rate was set at 35 L/min with FiO 2 at 35%. These parameters were adjusted according to the discretion of the investigating physician to ensure optimal oxygenation and comfort for the subject. The settings were again confirmed by the attending physician prior to the initiation of the study. Overall study design. Enrolled patients received both types of oxygen therapy, nasal cannula (NC) and high flow nasal cannula (HFNC). The sequence of oxygen therapy, NC followed by HFNC or HFNC followed by NC, was randomized with each type of oxygen therapy lasting for 20 minutes. Efficacy and subjective discomfort associated with each treatment were assessed at the end of each therapy type. ABGA: arterial blood gas analysis; EIT: electric impedance tomography. 
Electric Impedance Tomography
Statistical Analysis
Continuous variables are presented as mean ± standard deviation and categorical variables as numbers with percentages. Data between HFNC and NC were compared using paired t-tests for continuous variables and chi-square tests for categorical variables. CoV was calculated as Fifteen of the patients (62.5%) were male. The primary causes of hypoxia in the patients were pneumonia in nine patients (37.5%), acute exacerbation of chronic obstructive pulmonary disease in three patients (12.5%), acute pulmonary edema in three patients (12.5%), sepsis in five patients (20.8%), pleural effusion in two patients (8.3%), asthma in one patient (4.2%) and hemoptysis in one patient (4.2%). Prior to the study, the patients were all receiving oxygen therapy using NC, with a flow rate of 3.0 ± 1.6 L/min. The baseline characteristics and comorbidities of the subjects are shown in Table 2 .
Thirteen patients received HFNC first, followed by NC, and 11 patients received their therapy in the reverse order. Mean flow rate of HFNC was 34.2 ± 4.1 L/min and mean FiO 2 was 35.6% ± 1.6%. After initiation of HFNC therapy, the setting value was changed in four patients.
One patient complaint of headache and flow rate of regard to arterial blood gas, PaO 2 levels were higher during HFNC than in NC (NC, 104.3 ± 29.0 mmHg; HFNC, 122.4 ± 28.7 mmHg; P = 0.007), whereas no significant difference in PaCO 2 levels (NC, 37.4 ± 6.5 mmHg; HFNC, 37.6 ± 7.2 mmHg; P = 0.728).
Compared with NC, the global TV of the lung was higher during HFNC (NC, 2,241 ± 1,381 AU; HFNC, 2,543 ± 1,534 AU; P < 0.001). TVs of the dorsal and ventral hemi-lung regions as well as the left and right hemilung regions were consistently higher during oxygen therapy with HFNC than with NC (Table 3) . Regional
TVs for the four iso-gravitational quadrants of the lung were all higher during HFNC than NC ( Figure 3A) . In terms of the four gravitational layers of the lung, the two middle layers were increased during HFNC compared with NC ( Figure 3B ). However, regional TVs in the most ventral and most dorsal layers of the lung were not statistically different from NC.
When the TV was compared as quadrants, in the ROI where the TV was minimal during NC, the increase in TV In the assessment of perceived discomfort, scores for chest discomfort (NC, 1.00 ± 0.00; HFNC, 1.33 ± 0.70; P = 0.029) and noisiness (NC, 1.08 ± 0.28; HFNC, 2.04 ± 1.08; P < 0.001) were higher during HFNC compared with NC. However, other parameters showed no difference between the two therapies ( Table 4 ). The number of questions for discomfort scoring 4 or more, representing significant discomfort, were not statistically different between the two therapies and neither did the result with score 3.
dIscussIon
HFNC is emerging as an alternative to conventional oxygen delivery systems and as a noninvasive ventilation approach in selected patients. In patients with non-severe hypoxia, studies have shown that HFNC helps patients avoid intubation and results in better outcomes [7] [8] [9] . Of the few speculated advantages of HFNC, the PEEP effect is particularly attractive in that its beneficial effects may be achieved noninvasively. Increased TV has been reported in a previous study using EIT [10] , with HFNC in post-cardiac surgery patients associated with significantly higher TV.
Our study confirms these findings in nonsurgical patients. In patients with hypoxia in the present study, compared with conventional NC, HFNC resulted in (1) increased global ventilation, (2) increased regional ventilation in all four iso-gravitational quadrants of the lung, with decreased heterogeneity of the regions, and (3) increased regional ventilation of the two middle gravitational layers, and no change in the gravitational heterogeneity of ventilation.
We note several interesting findings on the regional characteristics of the increased ventilation during HFNC.
Firstly, regional ventilation of the iso-gravitational plane of the lung was higher, and the heterogeneity was lower compared with NC. However, regional ventilation along the dorso-ventral axis was higher only in the middle part of the lung during HFNC, while this was not the case in the most dorsal and ventral regions. Values are presented as mean ± standard deviation or number (%). Patients answered questions relating to perceived discomfort, with a score of 1 representing "not at all," score 2 "slightly," score 3 "moderate," score 4 "quite a bit," and a score of 5 "extreme." NC: nasal cannula; HFNC: high flow nasal cannula.
PaO 2 levels were also higher during HFNC than in NC.
Although FiO 2 levels during both HFNC and NC cannot be precisely controlled, studies on HFNC have consistently shown improved oxygenation compared with NC or reservoir masks. Our findings provide plausible explanations for this phenomenon [8, 11] . The regions with lowest ventilation during NC were receiving 37.6% more during HFNC, which likely translates into a better ventilation-perfusion ratio in the region. The decreased coefficient of variation for regional TVs, at least on the iso-gravitational plane of the lung, also supports this explanation.
In a previous study on regional lung ventilation during HFNC conducted in healthy subjects, a more homogeneous distribution during HFNC was found when compared to room air breathing [6] . To our knowledge, the present study is the first to evaluate regional ventilation characteristics during HFNC in patients with hypoxia.
Patients expressed more discomfort with HFNC in terms of chest discomfort and noisiness. However, the mean scores for HFNC were 1.33 and 2.04, respectively, which are lower than moderate in the degree of discomfort, and none of the subjects withdrew from the study due to intolerable discomfort. The respiration rate during HFNC was not lower than that during NC. This may be due to the characteristics of our subjects; baseline levels of hypoxia (PaO 2 104 mmHg on mean oxygen 3.0 L/min via nasal NC) and respiration rate (mean, 20.5/min) were both non-severe. Therefore, the benefits of HFNC on respiratory mechanics may have been less pronounced in our patients compared with subjects in the previous studies.
Applications for HFNC in adult patients are rapidly expanding for clinical indications, from simple acute respiratory failure to respiratory failure from diverse etiologies such as postoperative care [12, 13] , postextubation [9, 14, 15] , and possibly for mild acute respiratory distress syndrome. In previous studies, oxygen therapy using HFNC has focused on patients with moderate hypoxia [10, [12] [13] [14] [15] . In the present study, HFNC was applied in patients with a mild degree of hypoxia and who were being treated with low-flow oxygen. As this represents a highly prevalent patient group, our findings may have wider implications for HFNC at the bedside.
We tried to assess the difference of TV distribution according disease group and the in-homogeneous distribution of lung disease. However, defining the in-homogeneity was difficult to avoid being subjective. For example, with distribution of pneumonia in a patient, physicians can draw different conclusions. In addition, TV and CoV showed no significant difference between disease groups.
We tried to avoid describing homogeneity or in-homogeneity of lung disease.
The present study has several limitations. First, this is a non-blinded study in a small number of patients. Blinding
could not be achieved due to the distinct characteristics of each oxygen therapy. However, the order of oxygen devices was randomly allocated to patients to minimize bias. We also note a limitation in that data on global and In conclusion, during HFNC oxygen therapy, in addition to increased global ventilation, regional ventilation and its distribution was improved compared with conventional NC.
